Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Glucotrack (GCTK) Cash & Equivalents (2016 - 2020)

Historic Cash & Equivalents for Glucotrack (GCTK) over the last 7 years, with Q3 2020 value amounting to $10.7 million.

  • Glucotrack's Cash & Equivalents rose 77595.69% to $10.7 million in Q3 2020 from the same period last year, while for Sep 2020 it was $10.7 million, marking a year-over-year increase of 77595.69%. This contributed to the annual value of $419000.0 for FY2019, which is 33160.72% up from last year.
  • Latest data reveals that Glucotrack reported Cash & Equivalents of $10.7 million as of Q3 2020, which was up 77595.69% from $11.5 million recorded in Q2 2020.
  • In the past 5 years, Glucotrack's Cash & Equivalents registered a high of $12.4 million during Q1 2020, and its lowest value of $17345.0 during Q2 2018.
  • For the 5-year period, Glucotrack's Cash & Equivalents averaged around $2.4 million, with its median value being $696159.0 (2016).
  • In the last 5 years, Glucotrack's Cash & Equivalents tumbled by 9846.86% in 2018 and then skyrocketed by 4052852.56% in 2020.
  • Over the past 5 years, Glucotrack's Cash & Equivalents (Quarter) stood at $148836.0 in 2016, then plummeted by 63.86% to $53782.0 in 2017, then skyrocketed by 80.5% to $97079.0 in 2018, then soared by 331.61% to $419000.0 in 2019, then soared by 2455.29% to $10.7 million in 2020.
  • Its Cash & Equivalents was $10.7 million in Q3 2020, compared to $11.5 million in Q2 2020 and $12.4 million in Q1 2020.